Existential Distress, Serious Illness
Conditions
Keywords
Legacy Work
Brief summary
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Detailed description
This study is an investigator-initiated, multi-site Mayo Clinic prospective minimal risk pilot study to determine feasibility and acceptability of an AI Assisted Personalized Legacy Program. The AI Assisted Personalized Legacy Program intervention is a brief, individualized psychotherapy that aims to relieve psycho-emotional and existential distress and improve the experiences of patients whose lives are impacted by serious illness. This therapy offers patients an opportunity to reflect on their life with a trained facilitator and share their thoughts and memories with family and other people in their life. The sessions are recorded and transcribed. The interventionist will work with patients to edit the document and provide a final legacy document for patient to keep and give to loved ones.
Interventions
BEHAVIORALAI Assisted Personalized Legacy Program
AI Assisted Personalized Legacy Program will be facilitated by a clinician trained in legacy work.
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participant population: Adults with serious illness - defined as a health condition that carries a high risk of mortality Inclusion Criteria for patients: 1. Age ≥18 years 2. English fluency 3. Provide informed consent 4. Ability to complete questionnaire(s) by themselves or with assistance
Exclusion criteria
1. Other psychological co-morbidities such as untreated schizophrenia, bipolar disease 2. Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months 3. Active delirium 4. Advanced dementia 5. Participation in concurrent legacy offerings through the palliative care clinic
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility Number | 2 years | Study feasibility will be measured by the number of participants who enrolled and finished the study. |
| Acceptability | 5-10 days post-delivery of the final legacy document | Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items. |
Countries
United States
Contacts
CONTACTMelissa Felt
CONTACTDept. of Medicine Research Hub
PRINCIPAL_INVESTIGATORDeirdre Pachman, MD
Mayo Clinic in Rochester
PRINCIPAL_INVESTIGATORMark Edwin, MD
Mayo Clinic
Outcome results
None listed